Showing results (81-90 of 689) with videos related to

Sort By:
Pageof 69
Infection and Drug Resistance|July 2, 2020
Optimal Management of Complicated Infections in the Pediatric Patient: The Role and Utility of Ceftazidime/AvibactamMatteo Bassetti, Maddalena Peghin, Alessio Mesini, et al.
Future Microbiology|April 18, 2020
Update on the role of ceftazidime-avibactam in the management of carbapenemase-producing EnterobacteralesBeatriz Dietl, Laura M Martínez, Esther Calbo, et al.
Current Opinion in Infectious Diseases|October 12, 2021
New antibiotics for the treatment of nonfermenting Gram-negative bacteriaMatteo Bassetti, Chiara Russo, Antonio Vena, et al.
Infectious Diseases and Therapy|February 20, 2020
Mould Infections of Traumatic Wounds: A Brief Narrative ReviewDaniele Roberto Giacobbe, Niccolò Riccardi, Antonio Vena, et al.
Expert Review of Clinical Pharmacology|October 15, 2019
A look at clinical trial design for new antimicrobials for the adult populationMatteo Bassetti, Daniele Roberto Giacobbe, Maddalena Peghin, et al.
Frontiers in Medicine|May 2, 2019
Treatment of Infections Due to MDR Gram-Negative BacteriaMatteo Bassetti, Maddalena Peghin, Antonio Vena, et al.
Future Microbiology|August 12, 2025
Clinical impact of fluconazole-resistant Candida parapsilosis: a narrative reviewClaudia Bartalucci, Antonio Vena, Daniele Roberto Giacobbe, et al.
Current Opinion in Infectious Diseases|September 11, 2024
The role of sulbactam-durlobactam in treating carbapenem-resistant Acinetobacter infectionsMatteo Bassetti, Daniele Roberto Giacobbe, Nadia Castaldo, et al.
Current Opinion in Infectious Diseases|August 6, 2024
New antibiotics in clinical pipeline for treating infections caused by metallo-β-lactamases producing Gram-negative bacteriaMatteo Bassetti, Antonio Vena, Barbara Larosa, et al.
Pageof 69